Find Research Outputs

Search results

• 2018

  Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer

  Inoue, Y., Yamashita, N., Kitao, H., Tanaka, K., Saeki, H., Oki, E., Oda, Y., Tokunaga, E. & Maehara, Y., Aug 2018, In: Clinical Breast Cancer. 18, 4, p. e643-e650

  Research output: Contribution to journal › Article › peer-review

  • Protein Phosphatase 1
  • Phosphoric Monoester Hydrolases
  • Magnesium
  • Phosphoprotein Phosphatases
  • Breast Neoplasms
  3 Citations (Scopus)

• Clinicopathologic and molecular characteristics of synchronous colorectal carcinoma with mismatch repair deficiency

  Nakano, K., Yamamoto, H., Fujiwara, M., Koga, Y., Tsuruta, S., Ihara, E., Oki, E., Nakamura, M., Ogawa, Y. & Oda, Y., 2018, In: American Journal of Surgical Pathology. 42, 2, p. 172-182 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Turcot syndrome
  • DNA Mismatch Repair
  • Colorectal Neoplasms
  • Hereditary Nonpolyposis Colorectal Neoplasms
  • Neoplasms
  8 Citations (Scopus)

• Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102) (International Journal of Clinical Oncology, (2016), 21, 4, (705-712), 10.1007/s10147-015-0943-z)

  Miyamoto, Y., Tsuji, A., Tanioka, H., Maekawa, S., Kawanaka, H., Kitazono, M., Oki, E., Emi, Y., Murakami, H., Ogata, Y., Saeki, H., Shimokawa, M., Natsugoe, S., Akagi, Y., Baba, H. & Maehara, Y., Apr 1 2018, In: International Journal of Clinical Oncology. 23, 2, p. 402 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Medical Oncology
  • Oxaliplatin
  • Irinotecan
  • Bevacizumab
  • Japan

• Developing a Phosphospecific IHC Assay as a Predictive Biomarker for Topoisomerase I Inhibitors

  Ando, K., Tohme, Y. H., Srinivasiah, A., Taylor-Parker, J., Harrington, Y., Shah, A. K., Oki, E., Brahmandam, M. & Bharti, A. K., Aug 1 2018, In: Journal of Histochemistry and Cytochemistry. 66, 8, p. 549-561 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Topoisomerase I Inhibitors
  • Type I DNA Topoisomerase
  • Phosphotransferases
  • Biomarkers
  • Phosphoric Monoester Hydrolases

• Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors

  Takamori, S., Takada, K., Tagawa, T., Toyokawa, G., Hirai, F., Yamashita, N., Okamoto, T., Oki, E., Yoshizumi, T., Oda, Y. & Maehara, Y., Dec 2018, In: Surgical Oncology. 27, 4, p. 637-641 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cell Death
  • Ligands
  • Neoplasm Metastasis
  • Lung
  • Neoplasms
  5 Citations (Scopus)

• DNA replication stress and cancer chemotherapy

  Kitao, H., Iimori, M., Kataoka, Y., Wakasa, T., Tokunaga, E., Saeki, H., Oki, E. & Maehara, Y., Feb 1 2018, In: Cancer Science. 109, 2, p. 264-271 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • DNA Replication
  • Drug Therapy
  • Neoplasms
  • Genomic Instability
  • Biological Phenomena
  23 Citations (Scopus)

• Effect of age factors on health-related quality of life in patients with lower rectal cancer after sphincter-saving surgery: A 1-year longitudinal study

  Kinoshita, Y., Izukura, R., Miyazono, M., Nagai, S., Oki, E., Kanaoka, M., Nakao, H., Chishaki, A. & Mibu, R., Nov 1 2018, In: Archives of Gerontology and Geriatrics. 79, p. 185-191 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Age Factors
  • surgery
  • Rectal Neoplasms
  • cancer
  • Longitudinal Studies

• Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trial

  Shimizu, N., Oki, E., Tanizawa, Y., Suzuki, Y., Aikou, S., Kunisaki, C., Tsuchiya, T., Fukushima, R., Doki, Y., Natsugoe, S., Nishida, Y., Morita, M., Hirabayashi, N., Hatao, F., Takahashi, I., Choda, Y., Iwasaki, Y. & Seto, Y., Sep 1 2018, In: Surgery today. 48, 9, p. 865-874 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrectomy
  • Stomach Neoplasms
  • Length of Stay
  • Randomized Controlled Trials
  • Postoperative Complications
  12 Citations (Scopus)

• Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer

  Yamashita, N., Tokunaga, E., Iimori, M., Inoue, Y., Tanaka, K., Kitao, H., Saeki, H., Oki, E. & Maehara, Y., Oct 2018, In: Clinical Breast Cancer. 18, 5, p. e1003-e1009

  Research output: Contribution to journal › Article › peer-review

  • Vimentin
  • Cadherins
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Neoplasms
  24 Citations (Scopus)

• Erratum to: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition (Nature Medicine, (2018), 24, 7, (968-977), 10.1038/s41591-018-0022-x)

  Wong, G. S., Zhou, J., Bin Liu, J., Wu, Z., Xu, X., Li, T., Xu, D., Schumacher, S. E., Puschhof, J., McFarland, J., Zou, C., Dulak, A., Henderson, L., Xu, P., O’Day, E., Rendak, R., Liao, W. L., Cecchi, F., Hembrough, T., Schwartz, S. & 18 others, Szeto, C., Rustgi, A. K., Wong, K. K., Diehl, J. A., Jensen, K., Graziano, F., Ruzzo, A., Fereshetian, S., Mertins, P., Carr, S. A., Beroukhim, R., Nakamura, K., Oki, E., Watanabe, M., Baba, H., Imamura, Y., Catenacci, D. & Bass, A. J., Oct 1 2018, In: Nature medicine. 24, 10, p. 1627 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Mitogen-Activated Protein Kinase Kinases
  • Medicine
  • Actins
  • Neoplasms
  1 Citation (Scopus)

• Gastric cancer of "Crawling type" detected by additional gastrectomy after endoscopic submucosal resection

  Haruta, Y., Nakanishi, R., Jogo, T., Nakashima, Y., Saeki, H., Eiji, O. K. I., Fujiwara, M., Yoshinao, O. D. A. & Maehara, Y., Apr 2018, In: Anticancer research. 38, 4, p. 2335-2338 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrectomy
  • Stomach Neoplasms
  • Stomach
  • Gastroscopy
  • Biopsy
  1 Citation (Scopus)

• Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT

  Tsurumaru, D., Nishimuta, Y., Muraki, T., Asayama, Y., Nishie, A., Oki, E. & Honda, H., Nov 2018, In: European Journal of Radiology. 108, p. 165-171 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Stomach Neoplasms
  • Neoplasm Metastasis
  • Liver
  • Recurrence
  • Gastroscopy
  1 Citation (Scopus)

• Histopathologic evaluation of patients with liver-limited metastatic colorectal cancer receiving mFOLFOX6 plus bevacizumab or mFOLFOX6 plus cetuximab: The ATOM trial

  Emi, Y., Yamanaka, T., Muro, K., Uetake, H., Oki, E., Takahashi, T., Katayose, Y., Yoshida, K., Sakamoto, M., Aishima, S., Ishida, K., Imura, J., Unno, M., Hyodo, I., Tomita, N., Sugihara, K. & Maehara, Y., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii164

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer

  Hu, Q., Masuda, T., Sato, K., Tobo, T., Nambara, S., Kidogami, S., Hayashi, N., Kuroda, Y., Ito, S., Eguchi, H., Saeki, H., Oki, E., Maehara, Y. & Mimori, K., Mar 1 2018, In: Annals of Surgical Oncology. 25, 3, p. 745-753 9 p.

  Research output: Contribution to journal › Article › peer-review

  • ADP-Ribosylation Factors
  • Stomach Neoplasms
  • Datasets
  • Singapore
  • Genes
  15 Citations (Scopus)

• Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma

  Sato, S., Nagahashi, M., Koike, T., Ichikawa, H., Shimada, Y., Watanabe, S., Kikuchi, T., Takada, K., Nakanishi, R., Oki, E., Okamoto, T., Akazawa, K., Lyle, S., Ling, Y., Takabe, K., Okuda, S., Wakai, T. & Tsuchida, M., Dec 1 2018, In: Scientific reports. 8, 1, 1005.

  Research output: Contribution to journal › Article › peer-review

  • Adenocarcinoma of Lung
  • Atlases
  • Mutation
  • Genome
  • Neoplasm Genes
  11 Citations (Scopus)

• Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

  Oki, E., Samura, H., Okumura, H., Ohchi, T., Orita, H., Kobayashi, K., Kinjo, T., Mori, S., Touyama, T., Ohgaki, K., Kawanaka, H., Makiyama, A., Ureshino, N., Kotaka, M., Shimose, T., Saeki, H., Nishimaki, T., Baba, H. & Maehara, Y., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii166

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Laparoscopic Proximal Gastrectomy Maintains Body Weight and Skeletal Muscle Better Than Total Gastrectomy

  Sugiyama, M., Oki, E., Ando, K., Nakashima, Y., Saeki, H. & Maehara, Y., Oct 1 2018, In: World journal of surgery. 42, 10, p. 3270-3276 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrectomy
  • Skeletal Muscle
  • Body Weight
  • Stomach Neoplasms
  • Weight Loss
  13 Citations (Scopus)

• Low visceral fat content is a negative predictive marker for bevacizumab in metastatic colorectal cancer

  Miyamoto, Y., Oki, E., Emi, Y., Tokunaga, S., Shimokawa, M., Ogata, Y., Akagi, Y., Sakamoto, Y., Tanaka, T., Saeki, H., Maehara, Y. & Baba, H., Jan 2018, In: Anticancer research. 38, 1, p. 491-499 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Intra-Abdominal Fat
  • Bevacizumab
  • Colorectal Neoplasms
  • Survival
  • Confidence Intervals
  3 Citations (Scopus)

• Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress

  Kato, T., Satake, H., Oba, K., Kagawa, Y., Yasui, H., Nakamura, M., Watanabe, T., Matsumoto, T., Hirata, K., Muro, K., Komatsu, Y., Yoshino, T., Yamazaki, K., Mishima, H., Kotaka, M., Tsuji, A., Kakeji, Y., Oki, E., Nagata, N. & Sakamoto, J., Jun 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. v83

  Research output: Contribution to journal › Article › peer-review

  Open Access
  15 Citations (Scopus)

• Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?

  Saeki, H., Nakashima, Y., Kudou, K., Sasaki, S., Jogo, T., Hirose, K., Edahiro, K., Korehisa, S., Taniguchi, D., Nakanishi, R., Kubo, N., Ando, K., Kabashima, A., Oki, E. & Maehara, Y., Sep 1 2018, In: World journal of surgery. 42, 9, p. 2894-2901 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Sarcopenia
  • Chemoradiotherapy
  • Esophageal Neoplasms
  • Postoperative Complications
  • Esophageal Squamous Cell Carcinoma
  10 Citations (Scopus)

• Neoadjuvant chemotherapy versus chemoradiotherapy for patients with esophageal squamous cell carcinoma

  Nakashima, Y., Saeki, H., Hu, Q., Tsuda, Y., Hisamatsu, Y., Ando, K., Oki, E. & Maehara, Y., Dec 2018, In: Anticancer research. 38, 12, p. 6809-6814 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophageal Squamous Cell Carcinoma
  • Chemoradiotherapy
  • Drug Therapy
  • Esophageal Neoplasms
  • Survival
  2 Citations (Scopus)

• Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

  Kagawa, Y., Satake, H., Kato, T., Oba, K., Yasui, H., Nakamura, M., Watanabe, T., Hirata, K., Muro, K., Komatsu, Y., Yoshino, T., Yamazaki, K., Mishima, H., Kotaka, M., Tsuji, A., Kakeji, Y., Oki, E., Nagata, N. & Junichi, S., Nov 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. ix34-ix35

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Phase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601)

  Kobayashi, K., Iwatsuki, M., Orita, H., Hidaka, S., Arigami, T., Kusumoto, T., Satake, H., Oki, E., Satoshi, K., Tobimatsu, K., Shimokawa, M., Saeki, H., Makiyama, A., Kakeji, Y., Natsugoe, S., Baba, H., Eguchi, S. & Maehara, Y., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii225-viii226

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402)

  Tanioka, H., Miyamoto, Y., Tsuji, A., Asayama, M., Shiraishi, T., Yuki, S., Kotaka, M., Makiyama, A., Shimokawa, M., Shimose, T., Masuda, S., Yamaguchi, T., Komatsu, Y., Saeki, H., Emi, Y., Baba, H., Oki, E. & Maehara, Y., Apr 1 2018, In: Oncology (Switzerland). 94, 5, p. 289-296 8 p.

  Research output: Contribution to journal › Article › peer-review

  • regorafenib
  • Double-Blind Method
  • Dexamethasone
  • Fatigue
  • Colorectal Neoplasms
  3 Citations (Scopus)

• Rationale and design of the TRUSTY study: a randomised, multicentre, open-label phase II/III study of trifluridine/tipiracil plus bevacizumab versus irinotecan, fluoropyrimidine plus bevacizumab as second-line treatment in patients with metastatic colorectal cancer progressive during or following first-line oxaliplatin-based chemotherapy

  Yoshino, T., Oki, E., Nozawa, H., Eguchi-Nakajima, T., Taniguchi, H., Morita, S., Takenaka, N., Ozawa, D. & Shirao, K., 2018, In: ESMO Open. 3, 5, p. e000411

  Research output: Contribution to journal › Article › peer-review

  • trifluridine tipiracil
  • Oxaliplatin
  • Irinotecan
  • Bevacizumab
  • Colorectal Neoplasms

• Rationale and design of the TRUSTY study: A randomised, multicentre, open-label phase II/III study of trifluridine/tipiracil plus bevacizumab versus irinotecan, fluoropyrimidine plus bevacizumab as second-line treatment in patients with metastatic colorectal cancer progressive during or following first-line oxaliplatin-based chemotherapy

  Yoshino, T., Oki, E., Nozawa, H., Eguchi-Nakajima, T., Taniguchi, H., Morita, S., Takenaka, N., Ozawa, D. & Shirao, K., Aug 1 2018, In: ESMO Open. 3, 5, e000411.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • trifluridine tipiracil
  • Oxaliplatin
  • Irinotecan
  • Bevacizumab
  • Colorectal Neoplasms
  5 Citations (Scopus)

• Recent advances in treatment for colorectal liver metastasis

  Oki, E., Ando, K., Nakanishi, R., Sugiyama, M., Nakashima, Y., Kubo, N., Kudou, K., Saeki, H., Nozoe, T., Emi, Y. & Maehara, Y., May 2018, In: Annals of Gastroenterological Surgery. 2, 3, p. 167-175 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Neoplasm Metastasis
  • Colorectal Neoplasms
  • Drug Therapy
  • Liver
  • ErbB Receptors

• Recent incidence trend of surgically resected esophagogastric junction adenocarcinoma and microsatellite instability status in Japanese patients

  Imamura, Y., Watanabe, M., Toihata, T., Takamatsu, M., Kawachi, H., Haraguchi, I., Ogata, Y., Yoshida, N., Saeki, H., Oki, E., Taguchi, K., Yamamoto, M., Morita, M., Mine, S., Hiki, N., Baba, H. & Sano, T., Dec 1 2018, In: Digestion. 99, 1, p. 6-13 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophagogastric Junction
  • Microsatellite Instability
  • Adenocarcinoma
  • Incidence
  • Japan
  12 Citations (Scopus)

• Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)

  KYUSHU STUDY GROUP OF CLINICAL CANCER (KSCC), Dec 2018, In: European Journal of Cancer. 105, p. 41-49 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Trastuzumab
  • Stomach Neoplasms
  • Formaldehyde
  • Adenocarcinoma
  • Fixatives
  14 Citations (Scopus)

• Research of the cancer-odor

  Sonoda, H., Oki, E., Tanaka, M., Matsui, T., Onodera, T., Toko, K., Satoh, Y. & Maehara, Y., Jun 2018, In: Japanese Journal of Cancer and Chemotherapy. 45, 6, p. 911-915 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Odorants
  • Neoplasms
  • Smell
  • Happiness
  • Dreams

• REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan: Quality of life analysis

  Yoshino, T., Yamanaka, T., Denda, T., Tsuji, Y., Shinozaki, K., Komatsu, Y., Kobayashi, Y., Furuse, J., Okuda, H., Asayama, M., Akiyoshi, K., Kagawa, Y., Kato, T., Oki, E., Ando, T., Hagiwara, Y., Ohashi, Y. & Shitara, K., Jun 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. v95

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer

  Tsuchihashi, K., Ito, M., Moriwaki, T., Fukuoka, S., Taniguchi, H., Takashima, A., Kumekawa, Y., Kajiwara, T., Yamazaki, K., Esaki, T., Makiyama, A., Denda, T., Satake, H., Suto, T., Sugimoto, N., Katsumata, K., Ishikawa, T., Kashiwada, T., Oki, E., Komatsu, Y. & 8 others, Okuyama, H., Sakai, D., Ueno, H., Tamura, T., Yamashita, K., Kishimoto, J., Shimada, Y. & Baba, E., Dec 2018, In: Clinical Colorectal Cancer. 17, 4, p. e687-e697

  Research output: Contribution to journal › Article › peer-review

  • Colorectal Neoplasms
  • regorafenib
  • Drug Therapy
  • Progression-Free Survival
  • trifluridine tipiracil
  7 Citations (Scopus)

• Sarcopenia is an independent predictor of complications after colorectal cancer surgery

  Nakanishi, R., Oki, E., Sasaki, S., Hirose, K., Jogo, T., Edahiro, K., Korehisa, S., Taniguchi, D., Kudo, K., Kurashige, J., Sugiyama, M., Nakashima, Y., Ohgaki, K., Saeki, H. & Maehara, Y., Feb 1 2018, In: Surgery today. 48, 2, p. 151-157 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Sarcopenia
  • Colorectal Surgery
  • Colorectal Neoplasms
  • Postoperative Complications
  • Centers for Disease Control and Prevention (U.S.)
  34 Citations (Scopus)

• Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy

  Saeki, H., Emi, Y., Oki, E., Tokunaga, S., Kakeji, Y., Akagi, Y., Baba, H., Baba, E. & Maehara, Y., Jan 8 2018, In: BMC Cancer. 18, 1, 57.

  Research output: Contribution to journal › Article › peer-review

  • Phase II Clinical Trials
  • Oxaliplatin
  • Stomach Neoplasms
  • Drug Therapy
  • Japan
  1 Citation (Scopus)

• Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition letter

  Wong, G. S., Zhou, J., Liu, J. B., Wu, Z., Xu, X., Li, T., Xu, D., Schumacher, S. E., Puschhof, J., McFarland, J., Zou, C., Dulak, A., Henderson, L., Xu, P., O'Day, E., Rendak, R., Liao, W. L., Cecchi, F., Hembrough, T., Schwartz, S. & 18 others, Szeto, C., Rustgi, A. K., Wong, K. K., Diehl, J. A., Jensen, K., Graziano, F., Ruzzo, A., Fereshetian, S., Mertins, P., Carr, S. A., Beroukhim, R., Nakamura, K., Oki, E., Watanabe, M., Baba, H., Imamura, Y., Catenacci, D. & Bass, A. J., Jul 1 2018, In: Nature medicine. 24, 7, p. 968-977 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Mitogen-Activated Protein Kinase Kinases
  • Amplification
  • Chemical activation
  • Protein Tyrosine Phosphatases
  • Guanine
  65 Citations (Scopus)

• The clinical usefulness of the LigaSure™ small jaw in axillary lymph node dissection in patients with breast cancer

  Inoue, Y., Yamashita, N., Hiroki, U. E. O., Tanaka, K., Saeki, H., Eiji, O. K. I., Tokunaga, E. & Maehara, Y., Apr 2018, In: Anticancer research. 38, 4, p. 2359-2362 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Jaw
  • Lymph Node Excision
  • Breast Neoplasms
  • Drainage
  • Simple Mastectomy

• Thymidine kinase 1 loss confers trifluridine resistance without affecting 5-fluorouracil metabolism and cytotoxicity

  Edahiro, K., Iimori, M., Kobunai, T., Morikawa-Ichinose, T., Miura, D., Kataoka, Y., Niimi, S., Wakasa, T., Saeki, H., Oki, E., Kitao, H. & Maehara, Y., Oct 2018, In: Molecular Cancer Research. 16, 10, p. 1483-1490 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Trifluridine
  • thymidine kinase 1
  • Fluorouracil
  • trifluridine tipiracil
  • Pyrimidine Nucleotides
  5 Citations (Scopus)

• Treatment pattern and outcomes of trifluridine/tipiracil therapy for metastatic colorectal cancer in the real-world data from the JFMC50 study

  Kawakami, T., Yamazaki, K., Oki, E., Shimokawa, M., Takahashi, N., Yokota, M., Tokunaga, S., Esaki, T., Gamoh, M., Maeda, A., Tsuji, Y., Sakai, A., Hatanaka, K., Shimada, Y., Shiozawa, M., Komatsu, Y., Okuda, H., Ohue, M. & Maehara, Y., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii155

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Updated analysis of a phase II study of SOX plus trastuzumab for the patients with HER2 positive advanced or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS1501B

  Yuki, S., Shinozaki, K., Kashiwada, T., Kusumoto, T., Iwatsuki, M., Satake, H., Tokunaga, S., Emi, Y., Makiyama, A., Kawamoto, Y., Komatsu, Y., Shimokawa, M., Saeki, H., Oki, E., Baba, H. & Maehara, Y., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii225

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer

  Shibata, T., Tokunaga, E., Hattori, S., Watari, K., Murakami, Y., Yamashita, N., Oki, E., Itou, J., Toi, M., Maehara, Y., Kuwano, M. & Ono, M., Dec 14 2018, In: Oncotarget. 9, 98, p. 37216-37228 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Carrier Proteins
  • Biomarkers
  • Breast Neoplasms
  • Genes
  • University Hospitals

• Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer

  Shibata, T., Tokunaga, E., Hattori, S., Watari, K., Murakami, Y., Yamashita, N., Oki, E., Itou, J., Toi, M., Maehara, Y., Kuwano, M. & Ono, M., Dec 1 2018, In: Oncotarget. 9, 98, p. 37216-37228 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Carrier Proteins
  • Biomarkers
  • Breast Neoplasms
  • Genes
  • University Hospitals
  6 Citations (Scopus)

• “Energy-less technique” with mini-clips for recurrent laryngeal nerve lymph node dissection in prone thoracoscopic esophagectomy for esophageal cancer

  Saeki, H., Nakashima, Y., Hirose, K., Sasaki, S., Jogo, T., Taniguchi, D., Edahiro, K., Korehisa, S., Kudou, K., Nakanishi, R., Kubo, N., Ando, K., Kabashima, A., Oki, E. & Maehara, Y., Dec 2018, In: American Journal of Surgery. 216, 6, p. 1212-1214 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Recurrent Laryngeal Nerve
  • Esophagectomy
  • Esophageal Neoplasms
  • Lymph Node Excision
  • Surgical Instruments
  2 Citations (Scopus)
• 2019

  Amide proton transfer imaging to predict tumor response to neoadjuvant chemotherapy in locally advanced rectal cancer

  Nishie, A., Asayama, Y., Ishigami, K., Ushijima, Y., Takayama, Y., Okamoto, D., Fujita, N., Tsurumaru, D., Togao, O., Sagiyama, K., Manabe, T., Oki, E., Kubo, Y., Hida, T., Hirahashi-Fujiwara, M., Keupp, J. & Honda, H., Jan 2019, In: Journal of Gastroenterology and Hepatology (Australia). 34, 1, p. 140-146 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Amides
  • Rectal Neoplasms
  • Protons
  • Drug Therapy
  • Neoplasms
  8 Citations (Scopus)

• A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer

  Bando, H., Kagawa, Y., Kato, T., Akagi, K., Denda, T., Nishina, T., Komatsu, Y., Oki, E., Kudo, T., Kumamoto, H., Yamanaka, T. & Yoshino, T., May 14 2019, In: British journal of cancer. 120, 10, p. 982-986 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Circulating Tumor DNA
  • Multicenter Studies
  • Colorectal Neoplasms
  • Prospective Studies
  • Mutation
  9 Citations (Scopus)

• A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

  Kato, K., Satoh, T., Muro, K., Yoshikawa, T., Tamura, T., Hamamoto, Y., Chin, K., Minashi, K., Tsuda, M., Yamaguchi, K., Machida, N., Esaki, T., Goto, M., Komatsu, Y., Nakajima, T. E., Sugimoto, N., Yoshida, K., Oki, E., Nishina, T., Tsuji, A. & 11 others, Fujii, H., Kunieda, K., Saitoh, S., Omuro, Y., Azuma, M., Iwamoto, Y., Taku, K., Fushida, S., Chen, L. T., Kang, Y. K. & Boku, N., Mar 15 2019, In: Gastric Cancer. 22, 2, p. 344-354 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Nivolumab
  • Esophageal Neoplasms
  • Stomach
  • Placebos
  • ramucirumab
  20 Citations (Scopus)

• Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials

  Hirose, K., Oki, E., Shimose, T., Sakamoto, S., Sasaki, S., Jogo, T., Hu, Q., Tsuda, Y., Ando, K., Nakashima, Y., Saeki, H. & Mori, M., Nov 1 2019, In: International Journal of Clinical Oncology. 24, 11, p. 1397-1405 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Phase II Clinical Trials
  • Colorectal Neoplasms
  • Tomography
  • Drug Therapy
  • Response Evaluation Criteria in Solid Tumors

• C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer

  Kudou, K., Saeki, H., Nakashima, Y., Kamori, T., Kawazoe, T., Haruta, Y., Fujimoto, Y., Matsuoka, H., Sasaki, S., Jogo, T., Hirose, K., Hu, Q., Tsuda, Y., Kimura, K., Ando, K., Oki, E., Ikeda, T. & Maehara, Y., Feb 1 2019, In: Journal of Gastroenterology and Hepatology (Australia). 34, 2, p. 355-363 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Esophagogastric Junction
  • C-Reactive Protein
  • Stomach Neoplasms
  • Albumins
  • Adenocarcinoma
  15 Citations (Scopus)

• CT gastrography “wall-carving technique” of gastric cancer: impact of contrast enhancement based on layer depth

  Tsurumaru, D., Nishimuta, Y., Muraki, T., Asayama, Y., Nishie, A., Oki, E. & Honda, H., Aug 20 2019, In: Japanese Journal of Radiology. 37, 8, p. 597-604 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Stomach Neoplasms
  • Radiologists
  • Histology
  • Stomach
  • Retrospective Studies

• Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level

  Kataoka, Y., Iimori, M., Niimi, S., Tsukihara, H., Wakasa, T., Saeki, H., Oki, E., Maehara, Y. & Kitao, H., Dec 1 2019, In: Scientific reports. 9, 1, 7964.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Trifluridine
  • thymidine kinase 1
  • trifluridine tipiracil
  • DNA
  • Colorectal Neoplasms
  4 Citations (Scopus)

• Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial

  Oki, E., Shimokawa, M., Ando, K., Murata, A., Takahashi, T., Maeda, K., Kusumoto, T., Munemoto, Y., Nakanishi, R., Nakashima, Y., Saeki, H. & Maehara, Y., Mar 2019, In: Surgery (United States). 165, 3, p. 586-592 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Rectal Neoplasms
  • Lymph Node Excision
  • Randomized Controlled Trials
  • Recurrence
  • Adjuvant Chemotherapy
  4 Citations (Scopus)